Mianserine Teva (Mianserin Hydrochloride)

Mianserin acts by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine. It also antagonizes histamine H1 and serotonin 5‑HT2/5‑HT3 receptors, leading to enhanced noradrenergic and serotonergic neurotransmission that helps alleviate depressive symptoms.

The appropriate dose of Mianserine Teva is determined by the prescribing clinician based on the individual patient's condition, response, and tolerability. Dosage adjustments are made according to clinical guidelines and patient-specific factors.

Safety data for mianserin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mianserine Teva belongs to the tetracyclic class, differing from SSRIs and SNRIs in its receptor profile. It tends to cause more sedation and weight gain but has a lower risk of sexual dysfunction. Its unique mechanism may be advantageous for patients who do not respond to or cannot tolerate other antidepressant classes.

Mianserine Teva should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency.

Mianserine Teva is taken orally, usually with or without food, as directed by the prescribing physician. Swallow the tablet whole with a glass of water and follow the dosing schedule provided by the healthcare professional.

Serious risks include agranulocytosis, seizures, severe hypotension, cardiac arrhythmias (including QT prolongation), and the emergence or worsening of suicidal thoughts. Patients should be monitored closely for these events, especially during treatment initiation or dose changes.

Mianserine Teva is contraindicated in patients taking monoamine oxidase inhibitors, those with known hypersensitivity to mianserin, and individuals with severe hepatic impairment. Caution is also advised for patients with a history of cardiac arrhythmias, uncontrolled hypertension, or active suicidal ideation.